Found: 33
Select item for more details and to access through your institution.
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors.
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/7317964
- By:
- Publication type:
- Article
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15789, doi. 10.3390/ijms232415789
- By:
- Publication type:
- Article
Immune System and DNA Repair Defects in Ovarian Cancer: Implications for Locoregional Approaches.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 10, p. 2569, doi. 10.3390/ijms20102569
- By:
- Publication type:
- Article
Copy Number Analysis of 24 Oncogenes: MDM4 Identified as a Putative Marker for Low Recurrence Risk in Non Muscle Invasive Bladder Cancer.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 7, p. 12458, doi. 10.3390/ijms150712458
- By:
- Publication type:
- Article
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1221096
- By:
- Publication type:
- Article
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1221096
- By:
- Publication type:
- Article
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 412, doi. 10.3390/cancers15020412
- By:
- Publication type:
- Article
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092219
- By:
- Publication type:
- Article
Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical Implications.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5223, doi. 10.3390/cancers13205223
- By:
- Publication type:
- Article
Plasma Androgen Receptor in Prostate Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1719, doi. 10.3390/cancers11111719
- By:
- Publication type:
- Article
Combining liquid biopsy and functional imaging analysis in metastatic castration‐resistant prostate cancer helps predict treatment outcome.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 2, p. 538, doi. 10.1002/1878-0261.13120
- By:
- Publication type:
- Article
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.716467
- By:
- Publication type:
- Article
Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological Distress.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.564346
- By:
- Publication type:
- Article
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration‐resistant cancer patients.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 7, p. 1166, doi. 10.1002/ijc.33834
- By:
- Publication type:
- Article
Genome-wide plasma DNA methylation features of metastatic prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications.
- Published in:
- Disease Markers, 2016, p. 1, doi. 10.1155/2016/4358292
- By:
- Publication type:
- Article
Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients.
- Published in:
- Disease Markers, 2015, p. 1, doi. 10.1155/2015/574120
- By:
- Publication type:
- Article
Plasma AR and abiraterone-resistant prostate cancer.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 312, p. 1, doi. 10.1126/scitranslmed.aac9511
- By:
- Publication type:
- Article
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Testosterone levels and androgen receptor copy number variations in castration‐resistant prostate cancer treated with abiraterone or enzalutamide.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1211, doi. 10.1002/pros.23804
- By:
- Publication type:
- Article
Circulating androgen receptor gene amplification and resistance to <sup>177</sup>Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Carcinosarcoma of the prostate: case report with molecular and histological characterization.
- Published in:
- International Journal of Biological Markers, 2018, v. 33, n. 4, p. 540, doi. 10.1177/1724600818791463
- By:
- Publication type:
- Article
Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33774-4
- By:
- Publication type:
- Article
Endometrioid Cancer Associated With Endometriosis: From the Seed and Soil Theory to Clinical Practice.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.859510
- By:
- Publication type:
- Article
Cell-free DNA as a diagnostic marker for cancer: current insights.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 6549, doi. 10.2147/OTT.S100901
- By:
- Publication type:
- Article
Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16872, doi. 10.3390/ijms242316872
- By:
- Publication type:
- Article
Plasma AR Copy Number Changes and Outcome to Abiraterone and Enzalutamide.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.567809
- By:
- Publication type:
- Article
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.565857
- By:
- Publication type:
- Article
Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy.
- Published in:
- BioDrugs, 2016, v. 30, n. 4, p. 263, doi. 10.1007/s40259-016-0176-3
- By:
- Publication type:
- Article
GSTP1 methylation in cancer: a liquid biopsy biomarker?
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2018, v. 56, n. 5, p. 702, doi. 10.1515/cclm-2017-0703
- By:
- Publication type:
- Article